cd48 pe vio 770 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd48 pe vio 770
Cd48 Pe Vio 770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd48/CD48+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__06__27__734955-306-50-53
Average 93 stars, based on 51 article reviews
Cd48 Pe Vio 770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd48/CD48+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__06__27__734955-306-50-53
Average 93 stars, based on 51 article reviews
cd48 pe vio 770 - by Bioz Stars,
2026-09
93/100 stars
Images
1) Product Images from "Age-dependent disease tolerance to SARS-CoV-2 infection"
Article Title: Age-dependent disease tolerance to SARS-CoV-2 infection
Journal: bioRxiv
doi: 10.64898/2026.06.27.734955
Figure Legend Snippet: ( A ) Young Pnpla2 fl/fl and Pnpla2 AdipoQΔ/Δ mice were infected with MA-SARS-CoV-2 and BM was analyzed for early hematopoiesis at 5 dpi. ( B ) Representative flow cytometry plots showing c-KIT vs . Sca-1 gating on lineage-negative (Lin − ) cells to identify LKS (Lin − c-Kit + Sca-1 + ) hematopoietic stem and progenitor cells. Percentage and absolute numbers of ( C ) LKS (Lin − cKIT + Sca-1 + ) and ( D ) c-KIT + (Lin − cKIT + Sca-1 − ) cells. (E) Representative flow cytometry plots showing CD48 vs. CD150 gating on LKS cells to identify long-term hematopoietic stem cells (LT-HSC: CD150 + CD48 − ), short-term HSC (ST-HSC: CD150 − CD48 − ) and multipotent progenitor 2 (MPP2: CD150 + CD48 + ). Percentage and absolute numbers of ( F ) LT-HSC, ( G ) ST-HSC and ( H ) MPP2 cells. ( I ) Representative flow cytometry plots showing CD135 vs . CD34 gating on MPP cells to identify MPP3 (CD135 − CD34 + ) and MPP4 (CD135 + CD34 + ). Percentage and absolute numbers of (J) MPP3 and (K) MPP4 cells. Data shown as mean ± SD (C, D, F, G, H, J, K). Circles represent individual mice (n=7-11 per group, males & females). p values determined using two-way ANOVA. NS, not significant; *p < 0.05. Data pooled from three independent experiments with a similar trend.
Techniques Used: Infection, Flow Cytometry
Figure Legend Snippet: ( A ) Young (3 months) and old (>20 months) mice were infected with MA-SARS-CoV-2 and BM was analyzed for early hematopoiesis at 5 dpi. ( B ) Representative flow cytometry plots showing c-KIT vs. Sca-1 gating on lineage-negative (Lin − ) cells to identify LKS (Lin − c-Kit + Sca-1 + ) hematopoietic stem and progenitor cells. Percentage and absolute numbers of ( C ) LKS cells and ( D ) c-KIT + (Lin − cKIT + Sca-1 − ) cells. ( E ) Representative flow cytometry plots showing CD48 vs. CD150 gating on LKS cells to identify long-term hematopoietic stem cells (LT-HSC: CD150 + CD48 − ), short-term HSC (ST-HSC: CD150 − CD48 − ), and multipotent progenitor 2 (MPP2: CD150 + CD48 + ). Percentage and absolute numbers of ( F ) LT-HSC, ( G ) ST-HSC and ( H ) MPP2 cells. ( I ) Representative flow cytometry plots showing CD135 vs. CD34 gating on MPP cells to identify MPP3 (CD135 − CD34 + ) and MPP4 (CD135 + CD34 + ). Percentage and absolute numbers of ( J ) MPP3 and ( K ) MPP4 cells. Data are shown as mean ± SD (C, D, F, G, H, J, K). Circles represent individual mice (n=6 per group, males). p values were determined using two-way ANOVA. NS, not significant; *p < 0.05, **p < 0.01; ***p < 0.001. Data pooled from two independent experiments with a similar trend.
Techniques Used: Infection, Flow Cytometry
Related Articles
Blocking Assay:Article Title: Intrahepatic microbes govern liver immunity by programming NKT cells Article Snippet: .. After 8 blocking FcγRIII/II with an anti-CD16/CD32 mAb (eBioscience), cell labeling was 9 performed by incubating 106 cells with 1 μg of fluorescently conjugated antibody 10 directed against murine CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD11b (M1/70), 11 F4/80 (BM8), Gr-1 (RB6-8C5), CD11c (N418), MHC II (M5/114.15.2), CD80 (16-12 10A1), CD86 (GL-1), CD3 (17A2), TCRβ (H57-597), NK1.1 (PK136), Labeling:Article Title: Intrahepatic microbes govern liver immunity by programming NKT cells Article Snippet: .. After 8 blocking FcγRIII/II with an anti-CD16/CD32 mAb (eBioscience), cell labeling was 9 performed by incubating 106 cells with 1 μg of fluorescently conjugated antibody 10 directed against murine CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD11b (M1/70), 11 F4/80 (BM8), Gr-1 (RB6-8C5), CD11c (N418), MHC II (M5/114.15.2), CD80 (16-12 10A1), CD86 (GL-1), CD3 (17A2), TCRβ (H57-597), NK1.1 (PK136), Immunopeptidomics:Article Title: Intrahepatic microbes govern liver immunity by programming NKT cells Article Snippet: .. After 8 blocking FcγRIII/II with an anti-CD16/CD32 mAb (eBioscience), cell labeling was 9 performed by incubating 106 cells with 1 μg of fluorescently conjugated antibody 10 directed against murine CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD11b (M1/70), 11 F4/80 (BM8), Gr-1 (RB6-8C5), CD11c (N418), MHC II (M5/114.15.2), CD80 (16-12 10A1), CD86 (GL-1), CD3 (17A2), TCRβ (H57-597), NK1.1 (PK136), Control:Article Title: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1. Article Snippet: Differentiated or undifferentiated BLaER1 cells (3 × 105) were washed with FACS buffer (2% FCS, 2 mM EDTA, PBS) once and incubated for 15 min in 25 μl Fc Receptor Blocking Solution (BioLegend, 422302, 1:100 in FACS buffer) at 4 °C. .. 25 μl of isotype control (BioLegend, 400220 or 400120, 1:50) or specific antibody for CD14, Article Title: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1 Article Snippet: Differentiated or undifferentiated BLaER1 cells (3 × 10 5 ) were washed with FACS buffer (2% FCS, 2 mM EDTA, PBS) once and incubated for 15 min in 25 μl Fc Receptor Blocking Solution (BioLegend, 422302, 1:100 in FACS buffer) at 4 °C. .. 25 μl of isotype control (BioLegend, 400220 or 400120, 1:50) or specific antibody for CD14, Incubation:Article Title: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1. Article Snippet: Differentiated or undifferentiated BLaER1 cells (3 × 105) were washed with FACS buffer (2% FCS, 2 mM EDTA, PBS) once and incubated for 15 min in 25 μl Fc Receptor Blocking Solution (BioLegend, 422302, 1:100 in FACS buffer) at 4 °C. .. 25 μl of isotype control (BioLegend, 400220 or 400120, 1:50) or specific antibody for CD14, Article Title: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1 Article Snippet: Differentiated or undifferentiated BLaER1 cells (3 × 10 5 ) were washed with FACS buffer (2% FCS, 2 mM EDTA, PBS) once and incubated for 15 min in 25 μl Fc Receptor Blocking Solution (BioLegend, 422302, 1:100 in FACS buffer) at 4 °C. .. 25 μl of isotype control (BioLegend, 400220 or 400120, 1:50) or specific antibody for CD14, Staining:Article Title: NK cells shape the clonal evolution of B-ALL cells by IFN-γ production Article Snippet: .. The following antibodies (clones) were used for the staining: Article Title: E2f coordinates the cell cycle and cell fate of hematopoietic progenitors to drive stress myelopoiesis Article Snippet: .. The remaining white blood cells were stained with a cocktail of lineage antibodies (Cd3, Cd4, Cd8, B220, Ter119, Mac1 and Gr1) as well as antibodies against Kit, Sca1, Flk2/Flt3, Article Title: Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy Article Snippet: For detection of CAR-T and CAR-NK cell counts after the coculture, CAR-T cells were labeled with 1 μM CellTrace Violet and 1 μM CellTrace FarRed according to the manufacturer’s instructions, respectively (Thermo Fisher Scientific, Waltham, MA, USA). .. For evaluation of CAR-T and CAR-NK cell activation following coculture with tumor cells and MV, staining with CD3 (CD3 antibody, VioBlue, anti-human, REAfinity), CD16 (CD16 antibody, anti-human, PerCP-Vio700, REAfinity), OX40 (CD134 antibody, PerCP-Vio700, anti-human, REAfinity), NKG2D (CD314 antibody, PE, anti-human, REAfinity), DNAM-1 (CD226 antibody, PE-Vio770, anti-human, REAfinity), 2B4 (CD244 antibody, APC, anti-human, REAfinity), other:Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging Article Snippet: CD48 , Activation Assay:Article Title: Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy Article Snippet: For detection of CAR-T and CAR-NK cell counts after the coculture, CAR-T cells were labeled with 1 μM CellTrace Violet and 1 μM CellTrace FarRed according to the manufacturer’s instructions, respectively (Thermo Fisher Scientific, Waltham, MA, USA). .. For evaluation of CAR-T and CAR-NK cell activation following coculture with tumor cells and MV, staining with CD3 (CD3 antibody, VioBlue, anti-human, REAfinity), CD16 (CD16 antibody, anti-human, PerCP-Vio700, REAfinity), OX40 (CD134 antibody, PerCP-Vio700, anti-human, REAfinity), NKG2D (CD314 antibody, PE, anti-human, REAfinity), DNAM-1 (CD226 antibody, PE-Vio770, anti-human, REAfinity), 2B4 (CD244 antibody, APC, anti-human, REAfinity), |
